首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Efficacy of Mefipristone for induction of labour in late term pregnancy
【24h】

Efficacy of Mefipristone for induction of labour in late term pregnancy

机译:米非司酮在晚期妊娠引产中的功效

获取原文
           

摘要

Background: Late-term pregnancy defined as one that has reached between 41 0/7 weeks and 41 6/7 weeks of gestation is associated with an increased maternal morbidity as well as an increased risk of fetal and neonatal mortality and morbidity. Mifepristone, an anti-glucocorticoid and antiprogesterone, though not an oxytocic increases uterine activity and causes cervical effacement and dilatation and improves the Bishop score without over/hyper stimulation of uterus. Increased maternal and fetal mortality from late term pregnancy could be prevented by induction of labour. The objective of this study was to know the efficacy of single dose of oral mifepristone in induction of labour in late term pregnancy and to assess the induction delivery interval in the study population. Methods: This was a prospective interventional study conducted in Department of Obstetrics and Gynaecology at BGS Global Institute of Medical Sciences, Bengaluru. 100 Women with late term pregnancy who fulfilled the inclusion and exclusion criteria were considered for the study after an informed written consent. Results: 73.5% (n=36) of multigravida and 80.4% (n=41) of prim gravida showed improvement in the Bishop score post induction with mifepristone and majority (89.79 % primigravida and 84.31% multigravida) of the study population had vaginal delivery. Multigravida (73.5%) had less induction delivery interval (less than 48hours) compared to primigravida (19.6%). Conclusions: Mifepristone, a progesterone antagonist causes a significant improvement in the Bishop’s score and is associated with an increased rate of vaginal deliveries.
机译:背景:晚期妊娠定义为妊娠41 0/7周至41 6/7周之间的妊娠,与孕产妇发病率增加以及胎儿和新生儿死亡率及发病率风险增加有关。米非司酮是一种抗糖皮质激素和抗孕激素,尽管不是催产药,但它可以增加子宫活动并引起子宫颈浮肿和扩张,并在没有过度/过度刺激子宫的情况下提高Bishop评分。引产可以防止晚期妊娠增加的孕产妇和胎儿死亡率。这项研究的目的是了解单剂口服米非司酮在晚期妊娠引产中的功效,并评估研究人群的引产间隔。方法:这是在班加罗尔BGS全球医学科学研究所的妇产科进行的前瞻性干预研究。在知情的书面同意后,将100名符合纳入和排除标准的晚期妊娠妇女纳入研究范围。结果:73.5%(n = 36)的多胎孕妇和80.4%(n = 41)的初生孕妇在用米非司酮诱导后的Bishop评分有所改善,并且大部分研究人群(89.79%初产孕妇和84.31%的多孕妇)阴道分娩。与初孕妇(19.6%)相比,多孕妇(73.5%)的诱导递送间隔(少于48小时)短。结论:米非司酮是一种孕激素拮抗剂,可导致Bishop评分明显改善,并与阴道分娩率增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号